CHS/Pfizer Care Until Cure Research Program
Canadian Hemophilia Society (CHS)
This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders, including outcome evaluation. Grants are awarded for clinical research in fields relevant to improving the quality of life for persons with hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C, and carriers of an inherited bleeding disorder.
Funding up to $150,000 available for up to three years.
Results Announced: March 2024
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 21-Nov-2023 4:30 pm CST | 30-Nov-2023 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.